Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans
Takashi Yoshikado, Yukana Tomoda, Kouki Kasai, Reiki Toda, Satofumi Iida, Koji Chiba. Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans. // Drug Metabolism and Pharmacokinetics. – 2026. – DOI: 10.1016/j.dmpk.2026.101536. – URL: https://doi.org/10.1016/j.dmpk.2026.101536
Takashi Yoshikado, Yukana Tomoda, Kouki Kasai, Reiki Toda, Satofumi Iida, & Koji Chiba (2026). Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2026.101536
Takashi Yoshikado, et al. “Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans.” Drug Metabolism and Pharmacokinetics, 2026. doi:10.1016/j.dmpk.2026.101536.
@article{Yoshikado2026,
title = {Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans},
author = {Yoshikado, Takashi and Tomoda, Yukana and Kasai, Kouki and Toda, Reiki and Iida, Satofumi and Chiba, Koji},
journal = {Drug Metabolism and Pharmacokinetics},
year = {2026},
doi = {10.1016/j.dmpk.2026.101536},
url = {https://doi.org/10.1016/j.dmpk.2026.101536}
}